Home > Healthcare > U.S. Heparin Market > Table of Contents

U.S. Heparin Market Size By Product (Low Molecular Weight Heparin, Unfractionated Heparin), By Application (Venous Thromboembolism, Atrial Fibrillation/Flutter, Coronary Artery Disease), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

  • Report ID: GMI4868
  • Published Date: Nov 2020
  • Report Format: PDF

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    U.S. heparin industry 360° synopsis, 2015-2026

2.1.1    Business trends

Chapter 3   US Heparin Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2015 - 2026

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Growing prevalence of chronic diseases

3.3.1.2    High demand for anti-coagulant products

3.3.1.3    Rising geriatric population in U.S.

3.3.2    Industry pitfalls & challenges

3.3.2.1    High risk of side effects

3.3.2.2    High dependency on porcine

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By application

3.4.3    By distribution channel

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive landscape, 2019

3.7.1    Company share analysis, 2019

3.7.2    Company matrix analysis

3.8    PESTEL analysis

Chapter 4   US Heparin Market, By Product

4.1    Key segment trends

4.2    Low molecular weight heparin

4.2.1    Market size, 2015 - 2026 (USD Million)

4.3    Unfractionated heparin

4.3.1    Market size, 2015 - 2026 (USD Million)

Chapter 5   US Heparin Market, By Application

5.1    Key segment trends

5.2    Venous thromboembolism

5.2.1    Market size, 2015 - 2026 (USD Million)

5.3    Atrial fibrillation/flutter

5.3.1    Market size, 2015 - 2026 (USD Million)

5.4    Coronary artery disease

5.4.1    Market size, 2015 - 2026 (USD Million)

5.5    Others

5.5.1    Market size, 2015 - 2026 (USD Million)

Chapter 6   US Heparin Market, By Distribution Channel

6.1    Key segment trends

6.2    Hospital pharmacy

6.2.1    Market size, 2015 - 2026 (USD Million)

6.3    Retail pharmacy

6.3.1    Market size, 2015 - 2026 (USD Million)

6.4    Online pharmacy

6.4.1    Market size, 2015 - 2026 (USD Million)

Chapter 7   Company Profiles

7.1    Competitive dashboard, 2019

7.2    Amphastar Pharmaceutical

7.2.1    Business overview

7.2.2    Financial data

7.2.3    Product landscape

7.2.4    Strategic outlook

7.2.5    SWOT analysis

7.3    Changzhou Qianhong Biopharma Co , Ltd

7.3.1    Business overview

7.3.2    Financial data

7.3.3    Product landscape

7.3.4    Strategic outlook

7.3.5    SWOT analysis

7.4    Fresenius Kabi

7.4.1    Business overview

7.4.2    Financial data

7.4.3    Product landscape

7.4.4    Strategic outlook

7.4.5    SWOT analysis

7.5    Leo Pharma A/S

7.5.1    Business overview

7.5.2    Financial data

7.5.3    Product landscape

7.5.4    Strategic outlook

7.5.5    SWOT analysis

7.6    Nanjing King-Friend Biochemical Pharmaceutical

7.6.1    Business overview

7.6.2    Financial data

7.6.3    Product landscape

7.6.4    Strategic outlook

7.6.5    SWOT analysis

7.7    Pfizer, Inc

7.7.1    Business overview

7.7.2    Financial data

7.7.3    Product landscape

7.7.4    Strategic outlook

7.7.5    SWOT analysis

7.8    Sanofi

7.8.1    Business overview

7.8.2    Financial data

7.8.3    Product landscape

7.8.4    Strategic outlook

7.8.5    SWOT analysis

7.9    Shenzhen Hepalink

7.9.1    Business overview

7.9.2    Financial data

7.9.3    Product landscape

7.9.4    Strategic outlook

7.9.5    SWOT analysis

7.10    Yantai Dongcheng Biochemical Co , Ltd

7.10.1    Business overview

7.10.2    Financial data

7.10.3    Product landscape

7.10.4    Strategic outlook

7.10.5    SWOT analysis

 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2019
  • Companies covered: 10
  • Tables & Figures: 37
  • Countries covered: 1
  • Pages: 66
 Download PDF